CareDx

CDNA NASDAQ
38.07
+1.15
+3.11%
交易中 15:07 06/17 EDT
开盘
37.16
昨收
36.92
最高
38.25
最低
36.58
成交量
28.92万
成交均量(3M)
82.84万
52周最高
39.38
52周最低
10.31
换手率
0.69%
市值
16.04亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供CareDx CDNA股票价格,CareDx股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function having a low probability of moderate/severe acute cellular rejection. Its products under development for transplant monitoring include AlloSure, a development-stage transplant surveillance solution, which applies next generation sequencing to detect and quantitate genetic differences between donor-derived cell-free deoxyribonucleic acid (dd-cfDNA) in the blood stream emanating from the donor heart. It offers the AlloMap Score Variability service, which provides complementary information to help personalize long-term care of heart transplant recipients.
展开 >

最近浏览

名称
价格
涨跌幅